Asia Pacific is the fastest growing Single Nucleotide Polymorphism (SNP) Genotyping Market due to the rising demand of SNP genotyping in emerging economies by 2023

Single Nucleotide Polymorphism (SNP) is usually a mutation found at a specific locus or a single base pair mutation containing two alleles. SNPs aid in understanding the correlations among genotype and behavior indicated by all living organisms. SNP genotyping is the measurement of genetic variations that commonly occur in individuals. Unlike conventional time consuming, expensive and labor extensive detection technology, SNP technology is highly efficient, relatively inexpensive and automated.

Get the Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan

Analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants of many complex diseases. SNP technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases such as cancer, cardiovascular, Alzheimers, Asthma, and others.

In addition, SNPs are essential markers in various human ailments and are intensely employed in pharmacogenomics to customize personalized medicine in a better way. Therefore, rising applications of SNPs in several Life Sciences & Biotechnology aspects are driving the Single Nucleotide Polymorphism (SNP) genotyping market.

Furthermore, emerging technologies of SNP genotyping in the Life Sciences field such as Agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal & livestock breeding is expected to boost the market growth in the future. Other key factors driving the market are the rising prevalence of diabetes, cardiovascular diseases, and cancer. However, insufficient reimbursement policies limit the growth of SNPs genotyping market.

For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1464?utm_source=openpr&utm_medium=Niranjan

The Global Single Nucleotide Polymorphism (SNP) genotyping market is segmented on the basis of technologies, applications, and geography. Based on the technologies, the market is segmented into SNP Genechips and Microarrays, TaqMan Assay (Allele-Specific Hybridization), SNP, genotyping based upon Pyrosequencing, SN Plex based upon Applied Biosystems, Sequenom Masarray MALDI-TOF, RFLP (Restricted Fragment Length Polymorphism), SSCP (Single-Strand Conformation Polymorphism), ARMS (Amplification Refractory Mutation System) and Other SNP genotyping technologies. There are several application of SNPs that include Animal genetics, Plant improvement, Diagnostic research, Aquaculture, Pharmaceuticals and Pharmacogenomics, Agricultural Biotechnology, Animal Livestock and breeding, and Other SNP applications.

Amongst all the applications, pharmacogenomics and diagnostics are the most attractive application in this market. Geographically, the report is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA. North America is the dominating region in Single Nucleotide Polymorphism (SNP) genotyping market due to growing commercial research in personalized medicines, animal breeding, and others. In addition, Asia Pacific is the fastest growing market due to the rising demand for SNP genotyping in emerging economies such as China and India across different fields, which largely propel market growth.

Key strategies adopted by major players in this market include product launches, collaborations, and agreements. Recently, on April 13, 2015, Affymetrix Inc., collaborated with MTI Ltd. for personal genomics and genetic research services in Japan to expand their business in healthcare. Companies profiled in this report include Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, Affymetrix Inc., Sequenom, Inc., Roche Holding AG, Qiagen, Fluidigm Corporation, Agilent Technologies, Thermo Fisher Scientific Inc., and few others

KEY MARKET BENEFITS:
• Comprehensive analysis of factors that drive and restrict the growth of the Global Single Nucleotide Polymorphism (SNP) genotyping market is provided. For instance, the growing demand of SNPs in the drug development process will drive the market; however, insufficient reimbursement policies are likely to be a major restraint of the market.
• The projections in this report are made by analyzing the current market trends and the market potential for the forecast period of 2014-2020, in terms of value.
• A comprehensive analysis of technologies, applications and geography segments enables the identification of growth opportunities within the Global Single Nucleotide Polymorphism (SNP) genotyping market.
• Competitive intelligence (of leading manufacturers of Single Nucleotide Polymorphism (SNP) genotyping) helps in understanding the competitive scenario across geographies.
• A SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies.
• The report provides a quantitative analysis of the current market and estimations through 2014-2020 that help in identifying the prevailing market opportunities to capitalize on.
• Comprehensive analysis of all geographic regions is provided which helps in determining the prevailing opportunities across these geographies.

KEY MARKET SEGMENTS:

The Global Single Nucleotide Polymorphism (SNP) genotyping market is segmented into technology, application and geography segments.

Single Nucleotide Polymorphism (SNP) genotyping By Technology
• SNP Genechips and Microarrays
• TaqMan Assay (Allelle-Specific Hybridization)
• SNP genotyping based upon Pyrosequencing
• SN Plex based upon Applied Biosystems
• Sequenom Masarray MALDI-TOF
• RFLP (Restricted Fragment Length Polymorphism)
• SSCP (Single-Strand Conformation Polymorphism)
• ARMS (Amplication Refractory Mutation System)
• Other SNP genotyping technologies

Single Nucleotide Polymorphism (SNP) genotyping By Application
• Animal genetics
• Plant improvement
• Diagnostic research
• Aquaculture
• Pharmaceuticals and Pharmacogenomics
• Agricultural Biotechnology
• Animal Livestock and breeding
• Other SNP applications

Single Nucleotide Polymorphism (SNP) genotyping By Geography
• North America
• Europe
• Asia Pacific
• LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.